The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030” features an extensive study of the current market landscape and future opportunities associated with manufacturing of cell therapies.
To order this 550+ page report, please visit
this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Key Inclusions
§
A detailed review of the overall landscape of companies
that are engaged in the manufacturing of cell-based therapies, including
information on the type of cells manufactured (including immune cells
(including T cells, dendritic cells, NK cells), stem cells (including adult
stem cells, human embryonic stem cells and induced pluripotent stem cells) and
others), source of cells (autologous and allogeneic), scale of manufacturing,
type of cell cultures (adherent and suspension), purpose of production (fulfilling
in-house requirements and contract services), manufacturing capabilities /
services offered (including R&D, cell culture development, quality testing,
packaging, labelling, cell banking, cryopreservation, fill / finish services,
and regulatory affairs management), location of headquarters and location of
their respective manufacturing facilities.
§
An analysis of the various expansion initiatives undertaken
by service providers, in order to augment their respective cell
therapy
manufacturing capabilities, over the period 2015-2019 (till October), taking
into consideration parameters, such as year of expansion, type of cells, scale
of operation, purpose of expansion (facility expansion and new facility),
location of manufacturing facility, and most active players (in terms of number
of expansion initiatives undertaken).
§
An analysis of the recent partnerships focused on the
manufacturing of cell-based therapies, which have been established in the
period 2014-2019 (till November), based on various relevant parameters, such as
the year of agreement, type of partnership, type of cells, and scale of
operation (preclinical, clinical and commercial).
§
Informed estimates of the annual commercial and clinical
demand for cell therapies (in terms of number of cells produced and area
dedicated to manufacturing), which were further analyzed based on type of
cells.
§
An estimate of the overall, installed capacity for manufacturing
cell-based therapies based on information reported by industry stakeholders in
the public domain, highlighting the distribution of the available capacity on
the basis of scale of operation (clinical and commercial), size of the
organization (small, mid-sized and large firms) and key geographical regions
(North America, EU and Asia Pacific).
§
An in-depth analysis of cell therapy manufacturers using
three versatile representations, namely [A] a three dimensional grid analysis,
presenting the distribution of companies on the basis of type of cells
manufactured, scale of operation and purpose of production, [B] a logo
landscape based on the type of cells manufactured, geographical location of
manufacturer (North America, Europe and Asia Pacific) and type and size of
organization (non-industry players, and small, mid-sized and large companies),
and [C] a schematic world map representation, highlighting the geographical
locations of cell therapy manufacturing facilities of both industry and
non-industry stakeholders.
§
A detailed analysis of the various factors that are likely
to influence the pricing of cell-based therapies, featuring different models /
approaches that may be adopted by manufacturers while deciding the prices of
their proprietary offerings.
§
An elaborate discussion on the role of automation
technologies in improving current manufacturing methods, along with a
comparative (qualitive) analysis of cost differences between manual and
automated processes.
§
A qualitative analysis, highlighting the various factors
that need to be taken into consideration by cell therapy developers while
deciding whether to manufacture their respective products in-house or engage
the services of a CMO.
§
A discussion on cell
therapy
manufacturing regulations across various geographies, including the North
America (focusing on the US), Europe and Asia (focusing on Japan), featuring an
analysis of the diverse certifications / accreditations awarded to
manufacturing facilities by important regulatory bodies across the globe.
§
Elaborate profiles of key players (industry and
non-industry) that offer contract manufacturing services for cell-based
therapies; each profile includes an overview of the company / organization,
information on its manufacturing facilities, service portfolio details, recent
partnerships and an informed future outlook.
§
A discussion on affiliated trends, key drivers and
challenges, which are likely to impact the industry’s evolution, under a
comprehensive SWOT framework, which includes a Harvey ball analysis,
highlighting the relative effect of each SWOT parameter on the overall market
dynamics.
§
Insights generated in a market-wide survey, featuring
inputs solicited from experts who are directly and indirectly involved in the
development and / or manufacturing of cell-based therapies.
To request sample pages, please visit this -
https://www.rootsanalysis.com/reports/285/request-sample.html
Key
Questions Answered
§
What is the global demand for cell-based therapies?
§ Who
are the key manufacturers (industry / non-industry) of cell-based therapies,
across the world?
§ What
are the major recent developments (such as partnerships and expansions) in this
industry?
§ What
kind of partnership models are commonly adopted by stakeholders in this domain?
§ What
is the current, installed contract manufacturing capacity for cell therapies?
§ What
are the key factors influencing the make (manufacture in-house) versus buy
(outsource) decision related to cell therapies?
§ What
are the key parameters governing the cost of cell therapy manufacturing?
§ What
are important technology platforms (available / under development) for cell therapy development and
manufacturing?
§ What
are the key drivers and growth constraints in cell therapy manufacturing market?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
You
may also be interested in the following titles:
1.
Cell and Advanced
Therapies Supply Chain Management Market, 2019-2030
2.
RNAi Therapeutics
Market (2nd Edition), 2019 – 2030
3.
Gene Therapy Market
(3rd Edition), 2019 – 2030
4.
Stem Cell Therapy
Contract Manufacturing Market, 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment